After two years of construction and an investment volume of over 35 million euros, Judge Pharma ceremoniously opened the pharmaceutical production of the subsidiary Vetviva Richter in Wels. In the state -of -the -art production facility, the production of veterinary medicine medicines will be raised in the coming weeks. The new building is part of a comprehensive investment strategy and an essential contribution to medical security in our country. In addition, this gives a clear commitment to Austria’s economic and pharmaceutical location.
Wels, September 12, 2025 – Although the judges Pharma AG cannot escape economic developments such as increasing wage and energy costs, it is further expanding its role as an important pharmaceutical company in Austria. The company thus contributes to the stable and sustainable health care of humans and animals: On September 12, the group opened its new production center for veterinary medicinal products. Production will be gradually raised in the coming weeks.
Invested 35 million, secured 120 jobs
In January 2023 the groundbreaking for the new pharmaceutical production took place, two and a half years later the ambitious future project of Richter Pharma AG recorded the company. The investment volume amounts to around 35 million euros. Richter Pharma thus sets important value -added impulses in the region. At the same time, around 120 people will find an attractive and safe job in the new area. “”With this investment we strengthen our supply order for animal health with medicinal products ‘Made in Austria’“Mag. Roland Huemer, CEO of Richter Pharma AG, is convinced. “The new production complex is not only a milestone for Judge Pharma, but also for the country’s medical care security.” The pharmaceutical production now opened is part of a long-term growth and investment strategy. The company thus sets a strong impulse for the regional economy and generally the pharmaceutical location Austria.
Focus on animal health
The new production focuses on veterinary drugs, especially in the area of pain treatment. These drugs contribute significantly to animal health in dogs and cats, and for farm animals in the agricultural area also to ensure food quality. With the state -of -the -art filling line as a heart, judge Pharma can produce around 10 million bottles per year in the future – a tripling of the previous capacity! This is an important contribution to safe medication availability. The subsidiary Vetviva Richter is already holding almost 800 drug approvals and exports to over 50 countries worldwide.
Sustainability with system
Ensuring sustainability was a central objective of the project. The new building complex is connected to the district heating, uses heat recovery from refrigeration and steam systems and was equipped with a photovoltaic system. Thanks to high -tech water treatment, fresh water can be saved and process water can be used optimally with a high proportion of re -recycling.
About Richter Pharma AG
Richter Pharma AG is an international pharmaceutical manufacturer, logistian and full -whistle with its headquarters in Wels, Upper Austria. The company acts in the two large areas of “human medicine” and “veterinary medicine” and focuses on four business areas: pre-apartment for national and international pharmaceutical manufacturers, the fully sorted pharmaceuticals of medicinal products and health products for humans and animals and the production of veterinary medicinal products. The family company generated sales of 869 million euros in the 2024 financial year and employs 438 people at 5 locations in Austria. In 2024 the company was again awarded the “Work and Family” certificate.
More under www.richter-pharma.at.
More pictures in the APATAH-FOTOGALERIE
OTS original text press release with the exclusive in terms of content of the sender – www.ots.at | Nef